Breaking News Instant updates and real-time market news.

LXFR

Luxfer

$11.57

0.04 (0.35%)

17:02
10/10/16
10/10
17:02
10/10/16
17:02

Luxfer sees Q3 adjusted EPS about 12c below Q1, Q2 results, consensus 26c

Luxfer Chief Executive Brian Purves commented: "Demand has softened in a number of our markets, and defense in particular is below our prior view. As a result of the softening, there is near-term downside, particularly to sales of our magnesium products, and this will affect the Company's results. We currently expect Q3 Adjusted EPS to be approximately 12c below the results for Q1 and Q2 this year. We must assume that the current weakness in defense-related markets will persist at least until the end of 2016, and we have temporarily closed one magnesium powder facility and laid off employees at another of our magnesium business units." Purves added that the defense customer's unexpected outage at the end of May has lasted longer than anticipated, and other customers are reporting unusually low requirements for our magnesium-based products over the next few months, with normal demand for magnesium powder not expected to recover before Q1 2017. Purves continued, "We are working on several substantial commercial opportunities for magnesium products that we anticipate will help offset the weakness in some traditional markets. However, these opportunities are not yet firm as to size and timing. At this point, we believe the current low level of orders for magnesium products to be temporary, driven by near-term budgetary and other issues impacting our products more than in prior periods. The view that defense-related magnesium orders are temporarily delayed is supported by the recent award of a large contract for flare production by the U.S. military for 2017 production where we will be the powder supplier."

LXFR Luxfer
$11.57

0.04 (0.35%)

04/18/16
KEYB
04/18/16
UPGRADE
Target $16
KEYB
Overweight
Luxfer upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Philip Gibbs upgraded Luxfer Holdings to Overweight saying margins are bottoming given the successful restructuring of the company's Cylinders unit while growth is recovering in its zirconium business. The analyst has a $16 price target for the shares.

TODAY'S FREE FLY STORIES

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:39
01/19/18
01/19
06:39
01/19/18
06:39
Hot Stocks
Synchrony reports Q4 net interest margin 16.24% compared to 16.26% last year »

Return on assets was 1.6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

PB

Prosperity Bancshares

$74.26

-0.2 (-0.27%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Hot Stocks
Prosperity Bancshares announces stock repurchase program »

Prosperity Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 30

    Jan

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

, BIIB

Biogen

$344.44

-0.43 (-0.12%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Periodicals
Biogen among companies weighing bids for Acorda, Bloomberg reports »

Biogen (BIIB) and…

ACOR

Acorda Therapeutics

$25.00

0.25 (1.01%)

BIIB

Biogen

$344.44

-0.43 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Mar

SYF

Synchrony

$37.31

-0.75 (-1.97%)

06:38
01/19/18
01/19
06:38
01/19/18
06:38
Hot Stocks
Synchrony reports estimated Common Equity Tier 1 ratio 16% »

The estimated Common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

MRK

Merck

$61.13

-0.9 (-1.45%)

, AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

06:36
01/19/18
01/19
06:36
01/19/18
06:36
Hot Stocks
Merck, AstraZeneca: LYNPARZA receives approval in Japan »

AstraZeneca (AZN) and…

MRK

Merck

$61.13

-0.9 (-1.45%)

AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 02

    Feb

  • 08

    Feb

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 23

    Oct

GWR

Genesee & Wyoming

$81.57

0.18 (0.22%)

06:36
01/19/18
01/19
06:36
01/19/18
06:36
Hot Stocks
Genesee & Wyoming reports December traffic 255,199 carloads, down 5,7% y/y »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Hot Stocks
Synchrony reports Q4 net interest income up 8% to $3.9B »

Loan receivables grew $6…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

FHN

First Horizon

$20.21

-0.09 (-0.44%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Earnings
First Horizon reports Q4 EPS (20c) may not compare with consensus 30c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

AZN

AstraZeneca

$35.07

-0.01 (-0.03%)

06:34
01/19/18
01/19
06:34
01/19/18
06:34
Periodicals
AstraZeneca sees big productivity jump amid fewer drug projects, Reuters reports »

AstraZeneca has seen an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Feb

  • 08

    Mar

  • 23

    Apr

WIT

Wipro

$5.77

-0.11 (-1.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Earnings
Breaking Earnings news story on Wipro »

Wipro sees Q4 IT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIT

Wipro

$5.77

-0.11 (-1.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Earnings
Wipro reports Q3 revenue $2.1B, consensus $2.1B »

IT Services Segment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Hot Stocks
Breaking Hot Stocks news story on Citizens Financial »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

JAPAF

Japan Tobacco

$32.91

-0.29 (-0.87%)

06:33
01/19/18
01/19
06:33
01/19/18
06:33
Upgrade
Japan Tobacco rating change  »

Japan Tobacco upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:32
01/19/18
01/19
06:32
01/19/18
06:32
Hot Stocks
Citizens Financial raises quarterly dividend 22% to 22c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

PM

Philip Morris

$105.07

-0.72 (-0.68%)

, MO

Altria Group

$70.03

-0.12 (-0.17%)

06:31
01/19/18
01/19
06:31
01/19/18
06:31
Upgrade
Philip Morris, Altria Group, British American Tobacco rating change  »

Philip Morris upgraded to…

PM

Philip Morris

$105.07

-0.72 (-0.68%)

MO

Altria Group

$70.03

-0.12 (-0.17%)

BTI

British American Tobacco

$68.56

-0.82 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 01

    Feb

CFG

Citizens Financial

$45.76

-0.08 (-0.17%)

06:31
01/19/18
01/19
06:31
01/19/18
06:31
Earnings
Citizens Financial reports Q4 EPS $1.35 with items, consensus 67c »

Reports Q4 revenue $1.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 20

    Apr

  • 20

    Jul

  • 19

    Oct

SYF

Synchrony

$37.30

-0.76 (-2.00%)

06:30
01/19/18
01/19
06:30
01/19/18
06:30
Earnings
Breaking Earnings news story on Synchrony »

Synchrony reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

MO

Altria Group

$70.03

-0.12 (-0.17%)

06:30
01/19/18
01/19
06:30
01/19/18
06:30
Upgrade
Altria Group rating change  »

Altria Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 01

    Feb

JBHT

J.B. Hunt

$121.45

0.8 (0.66%)

06:28
01/19/18
01/19
06:28
01/19/18
06:28
Recommendations
J.B. Hunt analyst commentary  »

J.B. Hunt price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$27.68

0.175 (0.64%)

06:25
01/19/18
01/19
06:25
01/19/18
06:25
Periodicals
Emirates A380 order enables Airbus to maintain minimum production, Reuters says »

Emirates' recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$76.30

-0.28 (-0.37%)

, DAL

Delta Air Lines

$59.45

-0.27 (-0.45%)

06:23
01/19/18
01/19
06:23
01/19/18
06:23
Periodicals
United to offer premium economy on international flights, CNBC reports »

United Airlines (UAL) is…

UAL

United Continental

$76.30

-0.28 (-0.37%)

DAL

Delta Air Lines

$59.45

-0.27 (-0.45%)

AAL

American Airlines

$58.34

0.18 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 21

    Mar

LQ

La Quinta

$20.18

0.73 (3.75%)

, WYN

Wyndham

$122.73

5.6 (4.78%)

06:22
01/19/18
01/19
06:22
01/19/18
06:22
Recommendations
La Quinta, Wyndham analyst commentary  »

La Quinta price target…

LQ

La Quinta

$20.18

0.73 (3.75%)

WYN

Wyndham

$122.73

5.6 (4.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

GE

General Electric

$16.77

-0.58 (-3.34%)

06:19
01/19/18
01/19
06:19
01/19/18
06:19
Recommendations
General Electric analyst commentary  »

GE may be forced to raise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

GOOG

Alphabet

$1,129.79

-2.19 (-0.19%)

, GOOGL

Alphabet Class A

$1,135.97

-3.13 (-0.27%)

06:19
01/19/18
01/19
06:19
01/19/18
06:19
Periodicals
Google, Tencent sign patent licensing agreement, Bloomberg reports »

Alphabet's Google…

GOOG

Alphabet

$1,129.79

-2.19 (-0.19%)

GOOGL

Alphabet Class A

$1,135.97

-3.13 (-0.27%)

TCEHY

Tencent

$57.42

-0.505 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

BX

Blackstone

$34.91

-0.05 (-0.14%)

06:19
01/19/18
01/19
06:19
01/19/18
06:19
Periodicals
Blackstone hires Joe Zidle to succeed Byron Wien, WSJ reports »

Blackstone has hired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.